AbbVie Inc. (ABBV)

NYSE: ABBV · Real-Time Price · USD

256.10

+2.72 (1.07%)

At close: Jul 21, 2026, 4:00 PM EDT

255.42

-0.68 (-0.27%)

After-hours: Jul 21, 2026, 6:38 PM EDT

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Quarter	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Sep '25 Sep 30, 2025	Jun '25 Jun 30, 2025	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Sep '24 Sep 30, 2024	Jun '24 Jun 30, 2024	Mar '24 Mar 31, 2024	Dec '23 Dec 31, 2023	Sep '23 Sep 30, 2023	Jun '23 Jun 30, 2023	Mar '23 Mar 31, 2023	Dec '22 Dec 31, 2022	Sep '22 Sep 30, 2022	Jun '22 Jun 30, 2022	Mar '22 Mar 31, 2022	Dec '21 Dec 31, 2021	Sep '21 Sep 30, 2021	Jun '21 Jun 30, 2021	Mar '21 Mar 31, 2021	Dec '20 Dec 31, 2020	Sep '20 Sep 30, 2020	Jun '20 Jun 30, 2020
United States Revenue	10.97B
United States Revenue Growth	9.92%
International Revenue	4.03B
International Revenue Growth	19.89%
Revenue (Total)	15.00B
Revenue (Total) Growth	12.43%

Revenue

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Quarter	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Sep '25 Sep 30, 2025	Jun '25 Jun 30, 2025	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Sep '24 Sep 30, 2024	Jun '24 Jun 30, 2024	Mar '24 Mar 31, 2024	Dec '23 Dec 31, 2023	Sep '23 Sep 30, 2023	Jun '23 Jun 30, 2023	Mar '23 Mar 31, 2023	Dec '22 Dec 31, 2022	Sep '22 Sep 30, 2022	Jun '22 Jun 30, 2022	Mar '22 Mar 31, 2022	Dec '21 Dec 31, 2021	Sep '21 Sep 30, 2021	Jun '21 Jun 30, 2021	Mar '21 Mar 31, 2021	Dec '20 Dec 31, 2020	Sep '20 Sep 30, 2020	Jun '20 Jun 30, 2020
Immunology Revenue	7.29B
Immunology Revenue Growth	16.38%
Neuroscience Revenue	2.88B
Neuroscience Revenue Growth	25.99%
Oncology Revenue	1.63B
Oncology Revenue Growth	-0.12%
Aesthetics Revenue	1.19B
Aesthetics Revenue Growth	7.62%
Other Key Products Revenue	995.00M
Other Key Products Revenue Growth	22.99%
All Other Revenue	1.03B
All Other Revenue Growth	37.22%
Revenue (Total)	15.00B
Revenue (Total) Growth	12.43%